Steven G Arless

Steven G Arless is a Canadian entrepreneur in the biomedical technology industry. He has been CEO of a number of companies, most notably CryoCath Technologies (sold to Medtronic Inc. for C$400 million), Resonant Medical (sold to Elekta AB for $30 million), and CardioInsight (also sold to Medtronic for US $100 million).

Early life and education Arless was born in Montreal, Quebec on July 23, 1949. His father, an accountant, and his mother were immigrants to Canada from Lebanon. Arless studied Chemistry and Engineering at McGill University, graduating with a BSc. in 1971.

Career Arless is an angel investor in medical technology and is involved in mentorship and teaching of graduate students at McGill University and Concordia University and McGill University where he is a Professor of Practice. Arless was president and CEO of CryoCath from its inception until 2006, when he resigned. Arless stepped down from his position at CardioInsight in 2012.

Arless co-founded medical device company, Soundbite Medical Solutions, which fabricated wire devices to treat occlusions caused by coronary and peripheral artery disease with shockwaves. Arless stepped down as CEO in 2017.

As of early 2018, Arless has been MedTech Entrepreneur-in-Residence at Centech, a Montreal-based technology accelerator that strives to create new sustainable high tech business startups.

In late 2019, Arless co-founded and took the position as CEO of ViTAA Medical Solutions, a healthcare AI company specializing in 3D mapping of patients with aortic aneurysms that provide surgeons with clinical intelligence to guide therapy.

Awards Arless was awarded the Ernst & Young Entrepreneur of the Year award in 2005 for Health Sciences.